BIOGEN INC.
8-K
May 14, 2026
Key Highlights
- Completed $5.3 billion acquisition of Apellis Pharmaceuticals to expand specialt...
- Strategic integration of SYFOVRE® to offset revenue volatility in legacy product...
- Performance-based CVR structure aligns future payouts with specific drug sales m...
Read Analysis
🤖 AI Generated